Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint

• DRUSANO GL

収録刊行物

• Antimicrob Agents Chemother

  Antimicrob Agents Chemother 45 13-22, 2001

詳細情報

• CRID: 1573950399810453504
• NII論文ID: 80012145260
• データソース種別:
  • CiNii Articles